Brentuximab Vedotin and Pembrolizumab in Treating Patients With Recurrent Peripheral T-Cell Lymphoma March 13, 2021checkorphan Learn more about: Subcutaneous panniculitis-like T-cell lymphoma Related Clinical Trial A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas Brentuximab Vedotin and Pembrolizumab in Treating Patients With Recurrent Peripheral T-Cell Lymphoma Recruitment InformationAdministrative Informations
